McGill University Health Centre health news articles
Cannabis may offer relief to patients with chronic painThe medicinal use of cannabis has been debated by clinicians, researchers, legislators and the public at large for many years as an alternative to standard pharmaceutical treatments for pain, which may not always be effective and may have unwanted side effects.
Cannabis in teens can cause depression and anxietyCanadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought.
Improving heart attack treatment of patientsWhen faced with patients suffering a heart attack, doctors have two choices. One is to inject them with medication to dissolve the blood clot, that is fibrinolytic therapy, and second is to insert a small balloon to open the blocked artery i.e. primary percutaneous coronary intervention (PCI).
Folic acid prevents congenital heart defects by 6%The Canadian policy of fortifying grain products with folic acid has already proved to be effective in preventing neural tube defects. And the latest study shows that folic acid also decreases the incidence of congenital heart defects by more than 6%.
Treating HIV earlier is betterBegin treatment as early as possible: this general common sense rule seems to apply to most diseases except HIV-AIDS, which is only treated once a certain number of immune cells called "CD4+" cells have disappeared.
New risk factor for cardiovascular diseaseA team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease.
Weight loss bariatric surgery can cut cancer riskThe latest study by Dr. Nicolas Christou of the McGill University Health Centre (MUHC) and McGill University shows that Weight loss bariatric surgery decreases the risk of developing cancer by up to 80 percent.
Treatment of HIV associated Lipodystrophy SyndromeResearchers in Montreal and Boston have identified a potential new treatment for the HIV/HAART*-associated Lipodystrophy Syndrome. This syndrome is a common side-effect of anti-retroviral medications to treat HIV infection.
Health news organizations - M Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.